Poor
Not Aligned
Patient Risk:
High
Summary
The AI-generated claims are largely unsupported by the provided FDA label excerpts. Several safety-relevant statements (e.g., dose/frequency-dependent bleeding risk, specific bleeding risk factors, specific bleeding symptoms) are not supported in the available text, and food-specific guidance about avocado is not found in the provided labeling.
Category Scores
Accurate Statements
Taking aspirin regularly (for heart or stroke prevention) requires caution with any food or supplement that might also increase bleeding.
Partially supported only in the sense that the label excerpt (17 Patient Counseling Information: Risk of Bleeding) advises patients to notify their physician if prescribed any drug which may increase risk of bleeding. The provided labeling excerpt does not support food/supplement cautions or the heart/stroke prevention phrasing.
Other antiplatelets (clopidogrel) are relevant to increased bleeding risk.
Partially supported: label excerpt (17) states that as with other antiplatelet agents there is a general risk of bleeding. The provided excerpt does not name clopidogrel specifically.
Unsupported Statements
Aspirin can increase bleeding risk by affecting platelet function.
Mechanism (platelet function) is not supported by the provided label excerpts.
Avocado is generally considered low risk for bleeding on its own.
No label text provided discusses avocado or food-specific bleeding risk.
Aspirin commonly irritates the stomach.
No label text provided states stomach irritation.
Taking aspirin with food can reduce stomach irritation.
No label text provided supports this administration technique or benefit.
Eating avocado with a meal may be more comfortable than taking aspirin on an empty stomach.
No label text provided addresses avocado or comfort with/without food.
Eating avocado does not eliminate aspirin’s ulcer/bleeding risks.
No label text provided addresses avocado or whether any food eliminates ulcer/bleeding risks.
Whether avocado is a problem depends on the person’s overall situation rather than on avocado itself.
No label text provided discusses avocado relevance.
Taking aspirin daily or at higher doses increases bleeding risk.
The provided label excerpts do not specify daily use or dose-dependent bleeding risk.
A history of ulcers, GI bleeding, or gastritis is a factor relevant to aspirin-related risks.
The provided label excerpts do not list these as risk factors.
Blood thinners (warfarin, apixaban, rivaroxaban, dabigatran) increase bleeding risk when combined with other factors affecting bleeding.
No provided label text names these anticoagulants or combination effects.
Using NSAIDs besides aspirin is relevant to increased bleeding risk.
No provided label text addresses NSAIDs.
Black/tarry stools, vomiting blood, unusual bruising, or ongoing stomach pain after starting aspirin are symptoms that warrant prompt medical care.
While general bleeding-sign counseling is suggested by the excerpt (17), the specific symptom list is not provided in the supplied label text.
For everyday eating, avocado is typically fine with aspirin unless a clinician told you to avoid specific foods.
No provided label text supports avocado-specific permission or conditional food-avoidance guidance.
Contradictions
Important Omissions
Label-supported bleeding counseling specifics are incomplete relative to what the AI claims (e.g., the label excerpt references general bleeding risk including intracranial and gastrointestinal bleeding and to inform patients about signs/symptoms of bleeding, but does not include the specific symptom list and additional statements made by the AI).
Importance:
Moderate
No label-backed citations were provided for food/avocado-specific counseling; the excerpt supplied (17) addresses medications increasing bleeding risk and general bleeding-risk counseling, not dietary ingredient guidance.
Importance:
High
Safety Assessment
Potential Patient Risk:
High
Multiple safety-critical assertions are not supported by the provided FDA label excerpts, including statements about bleeding risk modifiers (dose/frequency, risk factors, drug classes) and specific bleeding symptoms. Additionally, avocado-specific reassurance and comfort statements are not present in the supplied label text, which could mislead patients regarding bleeding risk and when to seek care.
Regulatory Assessment
| On Label |
No |
| Off-label Discussion |
No |
| Promotes Unapproved Use |
No |
| Hallucination Risk |
High |
Recommendation
Not Aligned
Primary Issue
Most claims are unsupported by the provided FDA label excerpts, and several safety-relevant statements (symptoms, dosing/frequency dependence, specific interacting drugs/classes, and risk factors) are not evidenced in the supplied text; food/avocado guidance is absent from the provided labeling.
Suggested Improvement
Remove or rewrite avocado/food-specific guidance and dose/frequency/risk-factor/specific symptom claims unless they can be directly supported by the provided FDA label text. Keep only label-supported general counseling about bleeding risk and notifying a physician about prescribed drugs that may increase bleeding risk (per the supplied 17 excerpt), and ensure any named interactions/symptoms are present in the label sections (4/5/6/7/17) provided.